OSR HEALTH, INC. Retained Earnings
OSR HEALTH, INC. (OSRH) had Retained Earnings of -$40.95 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$40.95M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$40.10M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$37.17M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$32.33M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$40.95M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$40.10M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$37.17M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$32.33M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$30.18M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$30.57M 10-Q · filed 2025-05-20 | |
| 2024-12-31 | -$19.17M 10-K · filed 2026-03-31 | -$8.33M 10-K · filed 2025-04-22 |
| 2024-09-30 | -$5.75M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$4.90M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | -$4.31M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$3.91M 10-K · filed 2025-04-22 | |
| 2023-09-30 | -$2.46M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$2.09M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$1.83M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | -$62.51K 10-K · filed 2024-04-17 | |
| 2021-12-31 | -$27.12K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |